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Abstract 
Surgery is a most common source of acute pain and effective postoperative pain 
management is crucial for wound healing and recovery. Opiods are the mainstay for acute 
pain management but have various adverse effects including death. The multimodal 
approach involves the use of multiple drugs with varying mechanism of action to achieve 
optimal pain relief with less adverse effects. Intravenous acetaminophen (IVAPAP) is a 
new addition to the multimodal approach that appears to afford effective pain relief with 
a low risk profile. The purpose of this research study was to examine the impact of 
IVAPAP use in multimodal pain management on decreased opioid consumption and 
decreased average length of hospital stay in the post colectomy population. A 
comparative two group retrospective chart review was conducted, with a total of 72 
charts meeting the inclusion criteria. Group 1(n=36) study subjects who received 
IVAPAP for pain management were compared to Group 2(n=36) subjects who had not 
received IVAPAP after colectomy. Results demonstrated that Group 1, those who had 
received IVAPAP, used less opioids during the postoperative period as compared to those 
in Group 2 who had not received IVAPAP; there was no difference in length of stay 
between the groups. Further research related to the use of multimodal pain management 
strategies in general, and related to IVAPAP in particular, is indicated. Recommendations 
and implications for advanced practice nursing are presented and discussed.   
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Intravenous Acetaminophen Use in Postoperative Pain Management 
Background and Statement of the Problem 
Surgery is a most common and predictable source of pain in the hospital setting 
and postoperative pain is an expected outcome for people who undergo surgery. It has 
been estimated that more than 50 million inpatient surgeries are performed in the United 
States (US) annually (Centers for Disease Control [CDC], 2010). Fear of uncontrolled 
pain is one of the primary concerns of many patients who are undergoing surgery, and 
effective pain relief in the postoperative setting is a priority for patients and providers 
(Hutchison, 2007). Persistent acute pain unnecessarily taxes the body’s physiologic 
reserves and contributes to pulmonary complications, impaired rehabilitation and 
functional outcomes, development of chronic pain, and long term disability (Hartrick, 
2004). Unrelieved pain after surgery is highly prevalent and greatly impacts morbidity 
and mortality and can lead to an increase in readmission rates and length of stay, which 
contribute to higher healthcare costs (Hutchison). Effective pain control after surgery is 
important to prevent negative outcomes such as tachycardia, hypertension, myocardial 
ischemia, decrease in alveolar ventilation, immobility, deep vein thrombosis, and poor 
wound healing (Vadivelu, Mitra & Narayan, 2010).    
In recent years, there has been an increased awareness of the importance of pain 
management in our society. It has been over a decade since the U.S. Congress declared 
the Decade of Pain Control and Research and pain was identified and encouraged as the 
“fifth vital sign” to be used by the healthcare providers. In 2001, The Joint Commission 
(TJC) introduced standards that require healthcare organizations to make pain 
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management a primary organizational priority and mandated pain assessment and 
treatment as part of patient routine care (TJC, 2001). Despite these efforts, effective pain 
management is still a major healthcare issue.  
Treatment of acute postoperative pain remains suboptimal and approximately 
50% of patients experience moderate to severe pain during the postoperative period 
(Polomano, Rathmell, Krenzischek, & Dunwoody, 2008). Despite considerable 
advancements in the field of pain management, research indicates that a large proportion 
of patients still experience extreme levels of pain after surgical intervention. This has 
been highlighted consistently in the literature for almost forty years, illustrating the 
significance of the problem. Multimodal or balanced analgesia was developed a decade 
ago to improve postoperative pain management and reduce opioid-related side effects; 
evidence suggests that multimodal analgesia is becoming a 'standard of care' for 
postoperative pain management (Elvir-Lazo & White, 2010).  
The multimodal approach combines various analgesic techniques and different 
classes of drugs with varying mechanism of action to achieve additive or synergistic 
effects to provide superior pain relief (Pyati & Gan, 2007). This approach to 
postoperative pain management is associated with lower incidences of opioid related 
adverse effects, improved analgesia, shorter hospitalization times, and improved recovery 
and function (Buvanendran & Kroin, 2009). Opioids are very effective analgesics and a 
primary component of multimodal pain management approach in the postsurgical setting. 
However, they are associated with many undesirable side effects including nausea, 
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vomiting, sedation, constipation, physical dependence, tolerance, urinary retention, and 
respiratory depression (White, 2007).  
The American Society of Anesthesiologists (2004) practice guidelines for acute 
pain management in the perioperative setting recommended that unless contraindicated, 
all patients should receive an around-the-clock regimen of a non-opioid agent such as a 
nonsteroidal anti-inflammatory drug (NSAIDs) or acetaminophen. Thus, postoperative 
pain management regimens often include the non-opioid agents as adjuvant to opioid 
agents since non-opioids alone are not sufficient to treat moderate to severe pain (Smith, 
2011). In the US, there are a number of non-opioid oral analgesics that are approved and 
frequently used for acute pain treatment, either alone or in combination with opioids. 
Non-opioid analgesics include acetaminophen, aspirin, selective cyclo-oxygenase-2 
inhibitors (COXIBs) and NSAIDs. When oral administration is not feasible, ketorolac 
and ibuprofen are the only two approved intravenous (IV) non-opioid agents that are 
available in the US for multimodal pain management. Both are NSAIDs and use is very 
limited in the perioperative settings due to their adverse effect profile (Smith).  
Acetaminophen (APAP), known as paracetamol outside the US, has been 
available as an analgesic and antipyretic agent in the US since the 1950’s. It has an 
established record of safety, efficacy, and tolerance in adults and children. In the US, 
APAP is the most widely used analgesic and antipyretic agent and it is a first-line drug of 
choice for pain in the World Health Organization (WHO) step ladder approach to pain 
management (Duggan & Scott, 2009). The IV formulation of APAP (IVAPAP) was 
introduced and has been used outside the US since 2002. Use in the US was approved by 
4	  
	  
the FDA in 2010 under a brand name of Ofirmev for mild to moderate pain and for use in 
severe pain in combination with opioid analgesics. Its safety and tolerability profile is a 
greater advantage over other analgesic agents used for the treatment of postoperative 
pain. In contrast to opioids, acetaminophen does not produce sedation, respiratory 
depression, ileus, and constipation, and is also not associated with dependence or misuse 
(Cadence Pharmaceuticals, 2011).   
Abdominal surgery tends to be the most painful among all surgery types, and 70% 
of patients who undergo upper abdominal surgery suffer from severe pain (Chen et al., 
2009). Postoperative ileus is a persistent, gastrointestinal immobility that frequently occur 
three days post colorectal surgery (Chen et al.). Ileus results in nausea, vomiting, 
abdominal discomfort, delayed oral intake and increased length of hospitalization, which 
contributes to increased healthcare cost. Delayed bowel function is one of the most 
important and distressing side effects associated with opioid analgesic use in colorectal 
surgical patients (Chen, et al.). Recently, the study institution (The Miriam Hospital) 
added IVAPAP as additional non-opioid analgesic around the clock (1 gram q 6 hrs. for 
48 hrs.) along with an opioid regimen initiated in the inpatient surgical unit for post 
operative pain management in the colectomy population. Nurses play a major role in the 
management of patients’ pain following surgery as they are the healthcare professionals 
who provide 24-hour care at the bedside. Today, more than ever, RNs and APNs are 
challenged to provide high-quality and cost effective patient care. Nurses at the study 
institution had perceived a decrease in opioid consumption and average length of hospital 
stay among this surgical population since the use of IVAPAP for pain management. A 
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gap exists in research related to the relationship between effective postoperative pain 
management with IVAPAP and length of hospital stay.  
Studying the effect of intravenous acetaminophen use in postoperative pain 
management of the post colectomy population is clinically relevant. The purpose of this 
research study was to examine the impact of IVAPAP use in multimodal pain 
management on decreased opioid consumption and decreased average length of hospital 
stay in post colectomy population.  
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Review and Critique of the Literature 
An extensive literature review was conducted using the following databases: 
CINAHL; Ovid; Pub Med; Medline Plus, and Cochrane Library. The search was limited 
to articles published in the English language and from 1990 through the current year. 
Pain 
Melzack and Wall (2008) referred to pain as a puzzle and an exceptionally 
complex process for which one definition is not entirely satisfactory. The study of pain 
has evolved significantly in recent years and several distinguished contributions have 
been made toward an improved understanding of the nature of pain. Traditionally, pain 
was viewed solely in terms of the sensory component, whereby it was believed that pain 
was comprised only of a solitary sensory component that fluctuated only in intensity 
(Melzack & Wall). This hypothesis has been hugely modified and now we acknowledge 
and recognize that pain is a physiological manifestation that is significantly influenced by 
psychological components. The International Association for the Study of Pain defined 
pain as "an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage or described in terms of such damage" (IASP, 2011). The 
existence and intensity of pain are measured by the patient’s self-report. A clinical 
definition of pain states “Pain is whatever the experiencing person says it is, existing 
whenever he/she says it does” (McCaffery, 1968). Pain has been classified as 
nociceptive, inflammatory, and pathological based on its neurobiological perspective 
(Woolf, 2010).  
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Pain affects more Americans than diabetes, heart disease, and cancer combined 
and it is the most common reason Americans access healthcare (National Institutes of 
Health [NIH], 2010). According to the National Centers for Health Statistics (2006), 
approximately 76.2 million, one in every four Americans, have suffered from pain that 
lasts longer than 24 hours and millions more suffer from acute pain. It is a leading cause 
of disability and a major contributor to health care costs. Pain is a predictable experience 
after surgery due to tissue and nerve injury caused by the surgical procedure. Effective 
management of postoperative pain is a priority for patients and providers after surgery; 
the goal is to relive pain while keeping side effects to a minimum (Hutchison, 2007).  
The Institute of Medicine (IOM, 2011) published a report on advancing pain 
research, care, and education, which was subsequently mandated by the Patient 
Protection and Affordable Care Act. The report stated that at least 116 million US adults 
are burdened by chronic pain alone and the national economic cost associated with this is 
estimated to be 560 to 635 million US dollars. It was noted that addressing pain will 
require a cultural transformation in the way pain is understood, assessed, and treated. In 
addition, it was emphasized that healthcare providers, patients, and our society should 
overcome the misconceptions and biases about pain. It was also recommended that health 
care providers should keep their knowledge current by engaging in continuing education 
programs. This report urged healthcare providers, insurers, and the public to understand 
that pain is more than a physical symptom and is not always resolved by curing the 
underlying condition. Persistent pain can cause changes in the nervous system and 
become a distinct chronic disease (IOM).   
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Prevalence of Postoperative Pain     
Costantini, Viterbori, and Flego (2002) conducted a study aimed at determining 
the prevalence of pain among 4,709 eligible patients in 30 hospitals in Italy. Overall, 87% 
(4121 /4709) of in-patients were interviewed. At the time of the interview, 51.2% (n = 
2412) of the eligible patients were on medical wards, 46.4% (n = 2183) were on surgical 
wards, and 2.4% (n = 114) were on rehabilitation units. Over 56% of patients (n = 2333) 
had experienced pain in the previous 24 hours and almost 30% (n = 1178) had 
experienced pain of severe intensity.  Approximately 43% (n = 1750) of participants 
experienced pain during the interview and almost 12% of the pain experienced was 
severe in nature. The authors concluded that the pain prevalence was unacceptably high 
in most cases and age, sex, education, diagnosis, and days from surgery were 
significantly related to pain prevalence.  
Apfelbaum, Chen, Mehta & Gan (2003) conducted a national survey to assess 
patients’ postoperative pain experience and the status of acute pain management. The 
authors administered a questionnaire of patients' post operative pain experiences 
retrospectively. A total of 250 questionnaires were returned out of 666 requests for 
participation. Responders had undergone in-patient or out-patient surgery. More than half 
of these patients were concerned about postoperative pain (59%; n = 147), more than 
about success of surgery (51%; n =127). Approximately 80% (n =200) of patients 
experienced acute pain after surgery and about 75% (n =187) reported pain after 
discharge. Almost 82% (n =205) received pain medication and 27% (n = 68) experienced 
adverse effects, the most common of which were drowsiness, nausea, and constipation. 
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The authors concluded that there is a need for further changes in practice patterns, 
continued research, and development of newer analgesics with potent efficacy and 
minimal adverse effects. Use of balanced analgesia should enhance the potential to treat 
postoperative pain more successfully.  
Sommer et al. (2008) conducted a study aimed to measure the prevalence of 
postoperative pain in in-patient surgical patients. A total of 1975 subjects were eligible, 
of whom 1663 (85%) agreed to participate. Of these participants, only 1490 patients met 
the inclusive criteria. There were no significant differences in age and gender 
distributions between the non-responders and the participants. After admission to the 
surgical ward, a trained research assistant explained the purpose and methods of the study 
to each eligible patient. Pain measurement scores on a visual analogue scale were 
obtained on the day before surgery and on days 0-4 postoperatively. Results revealed that 
despite the presence of an acute pain protocol, 41% (n =610) of patients had moderate-to-
severe pain on the day of surgery, with almost 15% (n =223) experiencing moderate-to-
severe pain on the fourth postoperative day. The authors concluded that the postoperative 
pain management was unsatisfactory in in-patient surgical patients, especially after 
intermediate and major surgical procedures on an extremity or on the spine.  
Nasir, Howard, Joshi & Hill (2011) conducted a survey to describe the structure 
and function of the acute pain services (APS) in US hospitals. Acute pain services are 
aimed at alleviating postoperative pain by utilizing evidenced based approaches to pain 
management and providing a wider choice of analgesic techniques. A total of 108 
questionnaires were returned out of 301 requests for participation (35.9%). Of these 
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responses, 55 hospitals were university based teaching hospitals, 40 were non-teaching 
hospitals, and 13 were VA hospitals. The questionnaire was completed by the person who 
was in charge of postoperative pain management. The size of the hospitals varied: 21 
hospitals had fewer than 200 beds; 49 had 200-500 beds; 34 had 501-1000 beds; and four 
had more than 1000 beds. Results showed that 81 hospitals had an organized APS (75%) 
and 27 did not (25%). The likelihood of having an APS directly correlated with the 
hospital size, with the larger hospital having a better score on organized APS. 
Responding academic hospitals reported a higher rate of an organized APS (96%) when 
compared to private hospitals (47%), and VA hospitals (69%). These authors concluded 
that the structure and function of APS vary significantly among U.S hospitals. It further 
demonstrated that an organized APS with a written protocol adherence is more common 
in teaching hospitals than in either private or VA hospitals. This study emphasized pain 
intensity scores alone should not be used to evaluate improvement in pain management, 
and that the functional ability of patients and adverse effects of analgesic should be 
considered. 
Despite the wealth of research and knowledge about postoperative pain 
management that has been conducted for more than four decades, it is apparent that 
postoperative pain remains an unresolved or under treated major healthcare issue.  
Consequences of Unrelieved Postoperative Pain 
Extended periods of unrelieved acute pain can result in physiologic changes that 
include pituitary-adrenal activation. This results in diminished immune response that 
interferes in wound healing and sympathetic activation, which in turn may result in 
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cardiovascular, gastrointestinal, and renal changes. In addition, unrelieved postoperative 
pain causes the avoidance of movement and ambulation in post surgical patients 
(Hutchison, 2007). Ability to move and ambulation are the key elements in early surgical 
recovery and this inability may contribute to longer hospital stays and readmissions after 
discharge.   
Unrelieved acute pain affects the person's quality of life after surgery. Strassels, 
McNicol, Wagner, et al. (2004) conducted a study to assess patients who had undergone 
radical prostatectomy (RP), total hip replacement (THR), or total knee replacement 
(TKR) for pain, health-related quality of life, and physical social function at four weeks 
post hospital discharge. Participants completed the SF-­‐36 and questions from the 
Treatment Outcomes of Pain Survey (TOPS) four weeks after leaving the hospital. Total 
number of participants were 30 (RP = 15, TKR = 8, THR = 7). Postoperative pain 
interfered with patients’ ability to participate in desired activities (42.9% RP, 28.6% 
THR, 100% TKR), ability to sleep (21.4% RP, 71.4% THR, 75% TKR), and sexual 
functioning (50% RP, 28.6% THR, 25% TKR). During the first month after surgery, 
postoperative pain contributed to diminished health-­‐related QOL and interfered with 
activities important to patients. Patients in each surgical group demonstrated worse mean 
pain scores compared with US norms: the complaints were bodily pain, impaired physical 
functioning, and social functioning. Acute pain also substantially impaired patients’ 
sleep, sexual function, and ability to perform physical activities during the postoperative 
period.  
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Unrelieved and poorly controlled postoperative pain can negatively affect the 
perioperative outcome and risk for developing chronic pain (Yarnitsky, Crispel, 
Eisenberg et al., 2008). A greater proportion of patients who experienced acute 
postoperative pain developed chronic pain after surgery. Acute pain in the postoperative 
setting is a risk factor for developing chronic pain. Chronic post surgical pain is defined 
as patients' pain persisting for at least three months after a surgical intervention and with 
additional presence of a particular neuropathic pain. This pain has been also called 
persistent postsurgical pain (PPP) and it is estimated that about 50% of patients 
developing PPP after surgery (Cregg, Anwar, & Farquhar-Smith, 2013). Pain that persists 
well after surgical lesions have healed is prevalent and may occur after almost any 
surgery. While this was accepted as a negligible and normal phenomenon after surgery, it 
has now become recognized as an important clinical and perhaps social problem 
(Yarnitsky et al.). The one of many risk factors for developing PPP is the unrelieved 
postsurgical pain (Cregg et al.).  Based on the described studies, it is evident that 
unrelieved postoperative pain greatly affects the post-surgical patients' physical and 
physiological functions. Effective postoperative pain management is important and 
necessary for improving quality of life and minimizing patient morbidity.  
Intravenous Acetaminophen: Role in Postoperative Pain Management 
Healthcare providers can facilitate better pain control after surgery by 
implementing and applying evidence-based analgesic practices. The ultimate goal of 
postoperative pain management is choosing an effective, safe drug regimen with minimal 
adverse effects and maximum pain relief for effective patient outcomes (Smith, 2011). 
13	  
	  
Multimodal analgesic approach was introduced and has become the practice for 
postoperative pain management.  It involves the use of multiple agents that act at 
different regions of the pain pathway and opioids are the primary component in this 
regimen. The rational for this approach is that it reduces the use of opioids and their side 
effects (Elvir-Lazo & White, 2010). IVAPAP was first introduced in the U.S in 2010 
under a brand name of Ofirmev, although it was widely available in Europe for more than 
a decade. Its’ safety profile is supported by more than seven years of clinical post 
marketing safety experience outside the US and more than 60 years of clinical experience 
with oral and rectal acetaminophen (Wininger et al., 2010). The advantage of using 
IVAPAP in multimodal approach is that it is safe to use in conjunction with other drugs 
and has few clinically significant drug interactions. 
The recommended dosage in adults and adolescents weighing more than 50 
kilograms is one gram every six hours or 650 milligrams every four and a maximum 
daily dose of four grams. It is administered as a 15 minute infusion and may be given as 
single or repeated dose (Cadence Pharmaceuticals, 2011). The mechanism of 
acetaminophen-mediated pain relief is not well understood but research studies has been 
shown that it acts at both peripheral and central pain pathways (Smith, 2011). Intravenous 
APAP should be used with caution in patients with hepatic impairment or active hepatic 
disease, alcoholism, chronic malnutrition, severe hypovolemia or severe renal impairment 
and should not be used in patients with acetaminophen allergy (Cadence Pharmaceuticals, 
2011).  
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Sinatra et al.(2005) conducted a randomized, double-blind, placebo-controlled 
multi dose study in seven US centers to evaluate the analgesic efficacy and safety of 
IVAPAP compared with its prodrug (Propacetamol) and placebo. One hundred one 
subjects were randomized to receive either placebo or IVAPAP one gram for pain 
management after major orthopedic surgery. An additional 50 patients were treated with 
Propacetamol; that data is not included here since the drug is not approved to use in the 
US. Patients were started on the trial medication on postoperative day one to allow for 
anesthesia washout and ensure a stable baseline. Patients were allowed to use morphine 
via patient-controlled analgesia (PCA) in addition to as needed (PRN) bolus doses of 
morphine as a rescue medication. End points measured were pain relief, pain intensity, 
patient satisfaction, quantity of morphine consumed, and time to first use of rescue 
medication.  
Pain relief induced by IVAPAP one gram was significantly greater (79.6%) than 
with placebo (65.4%) and patients’ pain intensity score and median time to rescue 
medication were also better. Morphine consumption in IVAPAP group was 46% lower 
after the first dose and 33% lower over 24 hours as compared to placebo. There were no 
differences between the groups in experience of adverse effects and no serious hepatic 
events were reported in the IVAPAP group. Ninety seven patients (64.2%) experienced at 
least one adverse effect after the first administration of the study medication: 32 in the 
IVAPAP group, 32 in the placebo group, and 33 in the propacetamol group. The most 
common adverse reactions reported with >5% incidence and higher than placebo were 
nausea, vomiting, enlarged abdomen, coughing, and pruritus. Based on the study results, 
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the authors concluded that IVAPAP 1gram administered over a 24 hour period in patients 
with moderate to severe pain after major orthopedic surgery provided rapid and effective 
analgesia and was well tolerated.  
Macario and Royal (2010) performed a literature review of randomized clinical 
trials of IVAPAP for acute postoperative pain management to assess the analgesic 
outcomes of IVAPAP. This review included 16 articles from nine countries published 
between 2005 and 2010 and had a total of 1,464 patients. Twenty two study comparisons 
were analyzed: in eight studies IVAPAP was compared with active comparator 
(Parecoxib or Oral ibuprofen) and in 14 studies IVAPAP was compared with placebo. Of 
these participants, 780 patients received IVAPAP (n=1464). Seven out of eight 
comparator studies showed IVAPAP had similar analgesic outcomes as the comparator. 
The authors concluded that IVAPAP is an effective analgesic across a variety of surgical 
procedures. The limitations of the studies reviewed by the authors were the small sample 
size (in only five of 16 studies the IVAPAP group size exceeded 40 patients); small 
sample size studies are unlikely to identify clinically relevant side effects. Additionally, 
because the best analgesic approach needs to be individualized to the specific surgical 
procedure, results from a specific study may not be applicable to other surgery types or 
when other analgesic interventions are added to a multimodal approach (Macario & 
Royal).  
Intravenous Acetaminophen: Role in Abdominal Surgeries  
Wininger et al. (2010) conducted a randomized, double-blind, placebo-controlled, 
parallel-group study to evaluate the analgesic efficacy and safety of repeated doses of two 
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regimens of intravenous acetaminophen compared with placebo over 24 hours in subjects 
with moderate to severe pain after abdominal laparoscopic surgery. The study was 
conducted at 17 sites in the U.S. and 244 adult (aged 18-80 years) subjects were enrolled 
and randomized into four groups: IVAPAP 1000 mg (100ml) every six hrs; IVAPAP 650 
mg (65ml) every four hrs; IV placebo 65 ml every four hrs; IV placebo 100ml every six 
hrs.). Intravenous or oral opioid rescue was available to all subjects. The end points were 
pain intensity differences between groups. Additional end points included overall patient 
satisfaction, time to first rescue medication use, and total consumption of rescue 
medication over 24 hours. Pain relief and pain intensity scores significantly higher 
(86.9%) in IVAPAP group compared with placebo (70.3%). Patient overall satisfaction 
was significantly higher (74%) in patients received IV acetaminophen. There was no 
significant difference in rescue medication consumption between groups. Intravenous 
APAP 1000 and 650 mg groups had median times to first rescue that were not 
significantly longer than combined placebo group (10.4 and 16.4 respectively vs. 9.3 
hours). The most common adverse effects reported of any group were constipation, 
flatulence, nausea, and headache. This study concluded that both IVAPAP regimens (1 
gram every six hours and 650 milligrams every four hours) were associated with 
significant pain relief compared with placebo and were well tolerated in abdominal 
laparoscopic surgical patients (Wininger et al., 2010).  
Memis et al. (2010) conducted a study in patients undergoing major abdominal or 
pelvic surgery. The authors aimed to assess the analgesic efficacy, adverse effects, and 
time to extubation of IVAPAP after major surgery in an intensive care unit. They 
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randomized 40 ICU subjects into two groups: Group M, those receiving 100 ml of serum 
saline intravenous (IV) every 6 hours and IV meperidine (n = 20); or Group MP, who 
received IVAPAP 1 g every 6 hours and IV meperidine (n = 20, group MP). Both groups 
received the pain medications into a peripheral vein for 24 hours. Behavioral Pain Scale 
and VAS scores were significantly lower in group MP at 24 hours (P < .05). In group 
MP, postoperative meperidine consumption (76.75 ± 18.2 mg vs. 198 ± 66.4 mg) and 
extubation time (64.3 ± 40.6 min vs. 204.5 ± 112.7 min) were lower than in group M (P < 
.01). In addition, postoperative nausea-vomiting and sedation scores were significantly 
lower in group MP when compared with group M (P < .05). This data suggests that 
intravenous paracetamol is a useful component of the multimodal analgesia model, 
especially after major surgery.  
In summary, postoperative pain management continues to be a healthcare issue. 
Numerous studies and surveys have demonstrated that many patients experience 
moderate to severe pain postoperatively. Multimodal analgesia is increasingly utilized in 
the perioperative settings and has become a standard of care. Intravenous APAP is a new 
addition to the multimodal regimen. Studies have demonstrated the improved efficacy 
and tolerability of IVAPAP in post surgical patients.  
The purpose of this research study was to examine the impact of IVAPAP use in 
multimodal pain management on decreased opioid consumption and decreased average 
length of hospital stay in the post colectomy population.  
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Theoretical Framework 
Symptoms are of vital importance to healthcare professionals and are the central 
focus of the Theory of Unpleasant Symptoms (TUS) (1997) model. This theory was 
proposed as a means for integrating existing information about a variety of symptoms. 
The assumption behind this theory is that there are sufficient commonalities among 
symptoms to warrant a theory that is not limited to one symptom, but can explain and 
guide research and symptoms (Lenz, Pugh, Milligan, Gift, & Suppe, 1997). The Theory 
of Unpleasant Symptoms (TUS) proposes that the factors associated with a symptom may 
influence a number of different concurrent symptoms. Therefore, the use of therapeutic 
interventions aimed at lessening the severity of one symptom may be effective in 
alleviating other related symptoms.  
The TUS includes three reciprocal components including the symptoms that the 
individual is experiencing, the influencing factors giving rise to or affect the nature of the 
symptom experience, and the consequences of the symptom experience (Lenz et al., 
1997). Symptoms are described in dimensions of intensity, timing, level of perceived 
distress, and quality. These dimensions are influenced by three factors, including that of 
physiologic, psychological, and situational. The final component of the TUS is 
performance, the "outcome" or "effect" of the symptom experience. Performance is 
conceptualized to include functional and cognitive activities (Lenz et al.).  
The variables described in the TUS provide insight into the pain characteristics of 
post surgical patients. Multiple symptoms can occur together as a result of a single event 
or one symptom can precede another. For example, surgery is a single event that can 
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cause pain, fatigue, and nausea. The occurrence of two or more symptoms at the same 
time are likely to increase the intensity of each; for example, in post surgical patients, 
pain seems worst when the patient is experiencing nausea or fatigue. Unpleasant 
symptoms are subjectively experienced indicators that affect performance (Liehr, 2005). 
Postoperative pain can in turn affect performance, such as mobility and effective 
breathing. The performance outcome, recovery, is likewise influenced by the symptoms 
experiences of pain, nausea and fatigue. This study will focus on the opioid consumption 
for effective pain symptom management and the performance outcome of LOS.  
Using symptoms as a framework when caring for post-surgical patients can have a 
significant positive impact on post operative pain management.   
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Methods 
Purpose  
The aim of this research study was to examine the impact of intravenous 
acetaminophen use in multimodal pain management on decreased opioid consumption 
and decreased average length of hospital stay in the post colectomy population.  
Research Design 
This study employed a retrospective two group comparative chart review of adult 
patients who underwent colon resection. Group one (intervention) included subjects who 
received intravenous acetaminophen with opioid during the postoperative period. Group 
two (comparison) included subjects who did not receive intravenous acetaminophen. The 
independent variable was intravenous acetaminophen and dependent variables were the 
amount of opioid consumption and average length of stay. Key extraneous variables 
included age, BMI, laparoscopic vs. open surgical procedures, and gender. 
Sample and Setting 
The study sample was derived from a sample of 250 male and female patients 18 
years and older who received postoperative pain management for colon resection 
(colectomy), including both laparoscopic and open colectomy surgical procedures, that 
had occurred between March 2012 to October 2013. Exclusion criteria included patients 
who had undergone multiple surgeries, who had long term opioid use for chronic pain, a 
history of substance or opioid abuse, or history of dementia. The medical records office at 
The Miriam Hospital in Providence, RI was the site of the data collection. The Miriam 
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Hospital is a 247- bed academic acute care hospital, part of the Lifespan system and also 
a Brown teaching facility.  
Procedures 
Permission to conduct this study was obtained from the Lifespan and Rhode 
Island College Institutional Review Boards. Permission was also obtained from the 
hospital’s chief nursing officer. After approval, data were collected from February 2014 
to April 2014 until the target sample size was met, which was a minimum of 36 complete 
records in each group.  Colectomy procedures were identified by ICD 9 code and medical 
records were retrieved by the medical records management staff and placed on a shelf for 
the researcher to review. Paper records were examined for inclusion and exclusion 
criteria, and records meeting the inclusion criteria were reviewed further to extract the 
identified data.   
Measurement  
A researcher designed a data collection tool (Appendix A) was used, which 
included age, gender, body mass index, morphine or Dilaudid consumption, intravenous 
acetaminophen, morphine equivalent, and length of stay. The patients’ medical record 
number was used to retrieve data but not recorded on the data collection tool. A total 
amount of intravenous narcotics used during inpatient surgical unit stay was obtained 
from the patients medication administration records (MAR) and Patient Controlled 
Analgesia (PCA) flow sheets. Amount of dilaudid used was converted to morphine 
equivalence by used the equianalgesic calculator provided within the American Pain 
Society guidelines (Anderson, Saiers, Abram et al., 2001). Based on this calculator, one 
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mg IV dilaudid is equivalent to three mg of IV morphine which includes a 25% cross 
tolerance reduction. Length of stay was calculated by subtracting day of admission from 
day of discharge as per hospital practice.  
Upon completion of the research study, data will be stored for three years on an 
encrypted drive in a locked file on hospital premises to which only the PI has access and 
then will be destroyed. 
Data analysis 
Descriptive statistics were used to examine the study variables. The total amount 
of narcotics used was calculated, and morphine equivalence and LOS by group were 
compared using the T test.  
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Results 
A total of 149 records were reviewed. Seventy seven records were excluded based 
on the exclusion criteria and secondary to incomplete information .Seventy two records 
that met the inclusion criteria were reviewed, with 36 from each group. The demographic 
profile of study subjects is illustrated in Figure 1.  
 
Figure1. Demographic distribution of study participants 
Of the total number of study subjects (N=72), 62.5 % (n=45) were female and 
37.5% (n=27) were male. Approximately 75% of subjects (n=54) were 51-80 years of 
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age, about 20% (n=14) were less than 50 years of age, and the remainder (n=4; 5%) were 
greater than 80 years of age.    
Table 1 illustrates the range, average, and statistical significance of study 
variables between the IVAPAP group and the non IVAPAP group. 
Table1. Range, Averages, and Significance Level of Selected Data by Group  
  
Group 1 (IVAPAP) Group 2 (non IVAPAP) Significance 
(p) Range Average Range Average 
AGE(yrs.) 22 - 85 56.5 34 - 88 64 *0.015 
BMI 17.5 - 45  26.1 18.9 - 42.6 25.75 0.973 
MEQMS(mg) 6 - 150  36 7.2 - 160   38 0.324 
LOS(days) 1-9 4 1-11 4 0.131 
 
There was a statistically significant difference between ages of the groups 
(p=0.015), while average BMI was similar. The average use of morphine in Group 2 (non 
IVAPAP) was slightly higher (38 mg) as compared to Group 1 (IVAPAP) (36 mg), 
though the difference was not statistically significant. Average length of stay between the 
IVAPAP group and non IVAPAP group was the same, at four days. 
All study subject received opioids, either morphine or dilaudid, for postoperative 
pain management. Figure 2 illustrates the distribution of opioid use in morphine 
equivalence between the two groups.  
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Figure 2. Distribution of opioid use in morphine equivalence by group 
Morphine equivalence use is illustrated in Figure 2 by four categories: <51 mg; 
51-100 mg; 101-150 mg; and >150 mg. Almost 90% of overall study subjects (n= 66) 
used less than 101 mg of morphine equivalence. Slightly more subjects in Group 1 
(IVAPAP) used morphine equivalent doses in the lower range (< 51 mg); (23 vs. 22). 
Also, slightly more subjects in Group 2 (non IVAPAP) received doses within the 51-100 
mg (11 vs. 10) category. Only one subject in group 2 received >150 mg of morphine 
equivalence, the highest dose morphine category.  
Total sum of morphine equivalent dose for each group was calculated. Group 2 
(non IVAPAP) subjects received higher morphine equivalent (1869 mg) opiods as 
compared to group 1 (1625 mg). Most of the subjects in group 1 (n=23; 64%) were in the 
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lower dose (<51mg) morphine category and none of the study subject in group 1 
(IVAPAP) were in the highest morphine equivalent (>151) range.  
Figure 3 illustrates the length of hospital stay in days between Group 1 (IVAPAP) 
and Group 2 (non IVAPAP). 
 
Figure 3. Distribution of length of stay 
Approximately 47% (n=17) of study subjects from group 1 (IVAPAP) had a 
length of stay of one to three days, as compared to (n=11; 30%) in group 2 (non 
IVAPAP). Less subjects from Group 1 stayed more than three days overall (19 vs. 24). 
One study subject in group 2 (non IVAPAP) had a length of stay of more than ten days.  
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Summary and Conclusions 
Surgery is a most common and predictable source of pain in the hospital setting 
(Smith, 2011) and postoperative pain is an expected outcome for people who undergo 
surgery. Fear of uncontrolled pain is one of the primary concerns of many patients who 
are undergoing surgery (Hutchison, 2007), and effective pain relief in the postoperative 
setting is a priority for patients and providers. Persistent acute pain unnecessarily taxes the 
body’s physiologic reserves and contributes to pulmonary complications, impaired 
rehabilitation and functional outcomes, development of chronic pain, and long term 
disability (Hartrick, 2004). Insufficient pain control can contribute to various short-term 
and long-term complications, including low patient satisfaction, development of chronic 
pain syndromes, delayed postoperative rehabilitation and patient mobilization, atelectasis, 
deep vein thrombosis, and pulmonary embolism (Smith). Postoperative pain and its 
complications can be reduced with an appropriate postoperative analgesic regimen, and 
adequate pain relief reduces patients’ anxiety, morbidity, and duration of hospitalization, 
along with the associated costs of care (Duggan & Scott, 2009).  
In addition to postoperative opioid analgesics and NSAIDS, in recent years 
intravenous acetaminophen (IVAPAP) has been introduced and routinely administered in 
the inpatient postoperative period. The purpose of this study was to examine the impact of 
IVAPAP use in multimodal postoperative pain management on decreased opioid 
consumption and length of hospital stay in the post colectomy population.  
This study included a two group design and retrospective chart review was used to 
gather the data. Inclusion criteria included 250 male and female study subjects were 18 
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years and older who received postoperative pain management for colon resection 
(colectomy). Group 1 included patients who had received IVAPAP during the 
postoperative period; Group 2 included patients who had not received IVAPAP. A total of 
149 charts were reviewed, with 72 meeting the study criteria. Each group consisted of 36 
subjects. Data were collected related to age, gender, body mass index, opioid use in 
morphine equivalent and length of stay; the latter two were the key outcome variables.                
There was a difference between the groups on average morphine use, as 
determined by morphine equivalence; the IVAPAP group (Group 1) used less morphine as 
compared to the  non IVAPAP group (Group 2) but differences were not statistically 
significant ( 36 mg vs. 38 mg: p=0.324). However, Group 2 (non IVAPAP) subjects 
overall received higher morphine equivalence (1869 mg) of opiods as compared to Group 
1 (1625 mg). While it appeared that IVAPAP provided effective postoperative pain 
management, and the IVAPAP group tended to have lower opioid use, this study was not 
able to demonstrate a significant difference on opioid use. It is likely that the relatively 
small sample size lacked the power needed to demonstrate a significant difference.  
The overall length of hospital stay was the same for each group, at four days. 
Further analysis revealed that approximately 50% (n = 17) of the IVAPAP group had a 
length of stay less than three days, whereas only 30% (n = 11) of non IVAPAP subjects 
had a length of stay less than three days. It is also acknowledged that the length of hospital 
stay is controlled by many other factors like insurance coverage, provider preferences, and 
the availability of other outpatient services. 
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This study was limited by the relatively small sample size and the choice of 
retrospective design. Other limitations were encountered by the researcher during the data 
collection process. First, some data, particularly height and weight, were not recorded; 
since that data was needed to calculate BMI, those records without this data were excluded 
from the study. Also, all study subjects used Patient Controlled Analgesia pump (PCA) 
within the first 24 hours after surgery for pain control. Either morphine or dilaudid were 
used, and dosages were ideally totaled and hand recorded by the registered nurses every 
four hours on the PCA flow sheet exclusively. The subjects’ knowledge about using the 
PCA pump was unknown, and may have had an impact on opioid use. Missing or unclear 
amounts of opioid use were recorded, and it was very challenging for the researcher to 
obtain this data. Length of surgery is one of many factors that influence postoperative pain 
intensity (Ruiz-Suarez & Barber, 2008); it may have been helpful to collect data related to 
the length of surgery. Pain is a very subjective feeling; patients’ individual tolerance may 
have impacted the results. Though data related to gender was collected, there was no 
attempt to analyze data by gender. While recognizing that ethnicity impacts pain 
expression and tolerance, data related to ethnic status was not gathered. 
Postoperative pain is a common problem with serious potential adverse effects in 
terms of patient outcomes and healthcare costs. Opioid mono therapy is inadequate to treat 
postoperative pain, and NSAIDS have many adverse effects that limit their use in 
postoperative settings. Based on this study, it is concluded that using IVAPAP as a part of 
multimodal pain management can provide effective pain control and may contribute to 
less opioid use during the postoperative period in colectomy patients. Suggestions for the 
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study site included that further reinforcement related to the importance the recording of 
height and weight be considered, as well as the current method for recording PCA opioid 
consumption. Further research is needed to determine if IVAPAP is effective in reducing 
overall opioid consumption in a diverse sample of postoperative patients overall.  
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Recommendations and Implications 
Unrelieved pain is a major health care issue and one of the primary reasons that 
people seek health care. Pain after surgery is expected and it must be the healthcare 
providers’ priority to effectively manage that pain. The Joint Commission (2012) 
published a sentinel event alert; this report was a collection of opioid adverse effects 
including death that occurred between 2001 and 2011 in U.S. hospitals. The Joint 
Commission suggested that hospitals utilize evidence based practice to prevent opioid-
related adverse effects. 
Alleviating suffering is an essential part of nursing, which also has the 
responsibility to advocate for care needed by individuals, families, and communities. 
Nurses must be knowledgeable and skilled in assessment and management of pain 
because they are the healthcare providers with the most frequent patient contact and are 
in the best position to identity patients in pain. Advanced practice nurses, including NPs, 
have the advanced knowledge and skills to conduct comprehensive pain assessment and 
establish refined treatment plans for effective pain management. A primary 
recommendation for practice is that APRNs support and utilize multimodal analgesia 
approaches to achieve effective postoperative pain management. Nurse practitioners as 
members and leaders of the interdisciplinary team can be influential in advocating for 
effective pain management in general and for the use of emerging methods such as 
intravenous acetaminophen (IVAPAP) in particular.  
Acetaminophen has a proven safety and efficacy profile and IVAPAP is a safe 
addition to the currently available analgesics for pain management. Advanced practice 
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nurses have an important opportunity to educate nurses and members of the 
interdisciplinary team regarding the adverse effects and dosage information about 
IVAPAP. Before administering IVAPAP, nurse should be aware of the patients’ use of 
both prescription and nonprescription medications that contain acetaminophen in order to 
avoid exceeding the maximum daily dose. With proper use, the benefits of IVAPAP may 
reduce opioid consumption, minimize the incidence of opioid-related adverse events, 
improve pain relief, increase patient satisfaction, expedite mobilization and rehabilitation, 
and reduce health care costs.  
Undergraduate and graduate nursing programs need to enhance and expand 
teaching related to the complex pathophysiology of pain as well as comprehensive pain 
management strategies, both pharmacologic and non-pharmacologic. Nursing students 
must understand the highly individualized expression of pain and how pain is influenced 
by such factors as gender as ethnic background. Students as well as practicing nurses and 
other health care professionals should be supported and encouraged to participate in 
educational program and conferences to gain knowledge about emerging new 
interventions for effective pain management. In the past decade, improving health care 
quality is a major focus of healthcare reform efforts. Pain management has become a key 
outcome that is reflective of patient satisfaction within hospitals. The HCAHPS is a 
survey instrument and data collection methodology used to measure patients’ perceptions 
of their hospital experience, and in 2008 pain management questions were added in to 
this survey. Policy efforts at the national level need to continue to focus on enhancement 
of multimodal pain management strategies. Advanced practice nurse, in the leadership 
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role, have the ability to lobby national professional and policy making organizations to 
continue to advance research and evidence based guidelines related to effective pain 
management. As members of the interdisciplinary team, APRNs can be influential in 
ensuring that the most effective pain management strategies are implemented.  
Postoperative pain is still a major healthcare issue even with all these efforts and 
policies in place. Future research on analgesics, adjuvant, and holistic approached for 
pain management is crucial to achieve quality and effective pain management. While 
there is growing support in the literature for use of IVAPAP, further research, particularly 
nursing research, is needed, with larger samples and different target groups.  
In summary, the intense drive to measure quality is a concern for payers, 
regulators, and increasingly consumers. It will be imperative that APRNs are involved in 
the development of quality measures and evidence based practice. This study has 
established a foundation for further research opportunities in postoperative pain 
management. It may create awareness among nurses and the APRNs that there is still a 
need for new innovations and strategies to manage postoperative pain effectively.  
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Appendix A 
Data Collection Tool 
NO	   AGE	   SEX	   BMI	   TOS	   LOS	   DILAUDID	   MORPHINE	   IVA	   MEQ	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
 
No. = Subject ID #; BMI= Body Mass Index; TOS= Type of Surgery; LOS= Length of 
Stay; IVA = Intravenous Acetaminophen; MEQ = Morphine Equivalent;  
 
 
 
 
 
 
